However, a systematic literature search and meta-regression of published data on 13,080 SLE patients showed that at a low cut-off titer of ≥ 1:80, ANA had high sensitivity (97.8%, with a 95% confidence interval of 96.8–98.5%) [23]. This evidence concerns the gene BTG3 and systemic lupus erythematosus.